How Much Did Medtronic Stock Really Pay Its Holders?
Today’s big story: Could Anthropic Stock Fall 25%?
Medtronic (MDT) makes medical devices ranging from heart products in its Cardiovascular business to the Hugo surgical robot. The company has paid its holders a dividend in each of the past five years. Over the past year, those dividends added 3.5 percentage points to the stock’s return, against 1.2 points for the S&P 500. The share price, though, has trailed the market for much longer. So once every dividend is counted, how do you think a Medtronic holder did against the market over five years?

How Far Has Medtronic Stock Trailed The Market?
Over the five years from November 10, 2021 to November 18, 2026, Medtronic stock fell 17.7% on price alone, while the S&P 500 rose 57.5%. That left Medtronic 75.2 percentage points behind the market. Anyone who watched only the share price saw their stock lose ground in a rising market.
Medtronic shares ended five years 75.2 percentage points behind the S&P 500 on price alone. If its dividends pay a big part of your income, the savings that produce that income are worth less than five years ago. Our partner advisory firm will take your question on a free 30-minute call, by phone or video, with no obligation. Book a free call.
How Much Did Medtronic’s Dividends Add?
With dividends reinvested, a Medtronic holder still lost 3.5% over those five years. The dividends added 14.3 percentage points, making up most of the price fall, but not all of it.
Medtronic’s dividends did pay more than the market’s over this stretch. The S&P 500’s dividends added 10.9 points to its own five-year return.
Did The Dividends Close The Gap For Medtronic Holders?
Hardly, because the market paid dividends too. Here are the four five-year returns side by side.
| Return from Nov 10, 2021 to Nov 18, 2026 | On price alone | With dividends reinvested |
|---|---|---|
| The stock | -17.7% | -3.5% |
| S&P 500 | +57.5% | +68.4% |
Before taxes and costs. The S&P 500 is measured through the SPDR S&P 500 ETF.
With dividends counted on both sides, the S&P 500 returned 68.4%. Medtronic still trailed it by 71.8 percentage points. So Medtronic’s dividends closed only a small part of the gap, since the market’s own dividends added a good deal too.
What This Means If You Own Medtronic For Income
An income holder in Medtronic made a trade. Their dividends added more to their return than the market’s dividends added to its own. In return, they gave up far more in share price.
Medtronic’s dividend cash comes from selling medical devices. The Cardiovascular business, Medtronic’s largest, made up 38.4% of revenue in fiscal 2026. Over the past twelve months, Medtronic’s free cash flow came to 4.8% of its market value, above its 2.8% dividend yield.
On the September 1, 2026 call, management said free cash flow in the first quarter of fiscal 2027 was very strong. For anyone who owns Medtronic for income, the comparison that counts is its return with dividends against the S&P 500’s return with dividends.
Over five years, Medtronic paid its holders more in dividends than the market did, and they still ended far behind. Income does its job best when the price under it does not keep sliding.
More Income. Smaller Drops.
Is your portfolio paying you enough? The Trefis Income Solution holds 50 dividend stocks yielding about 3x the S&P 500, each with at least 10 straight years of dividends. It lost less than the S&P 500 in all 9 big selloffs since 2018. Why not choose a better approach?
Spot an error or want more like this? Tell us in 10 seconds.